---
figid: PMC7097090__41569_2019_244_Fig3_HTML
figlink: pmc/articles/PMC7097090/figure/Fig3/
number: Fig. 3
caption: Signalling through the type 2 angiotensin II receptor (AT2R) can directly
  inhibit AT1R activation and thus antagonize the effects of angiotensin II. Stimulation
  of AT2R can also inhibit extracellular signal-regulated kinase 1 (ERK1) and ERK2
  by activating Src homology region 2 domain-containing phosphatase 1 (SHP1) and mitogen-activated
  protein kinase-phosphatase 1 (MKP1), which can result in attenuation of cardiac
  hypertrophy. AT2R can also activate the transcription factor promyelocytic zinc
  finger protein (PLZF), thereby inducing the expression of ribosomal protein S6 kinase
  β1 (p70S6K) and p85α expression and, in turn, eliciting protein synthesis. In addition,
  AT2R might trigger vasodilatation by activating the phosphatidylinositol-3-kinase
  (PI3K)–AKT–endothelial nitric oxide synthase (eNOS)–nitric oxide (NO)–cGMP pathway
  either via angiotensin 1–9-mediated activation– or by heterodimerization with bradykinin
  B2 receptor (B2R). Phosphorylation of AKT by activation of AT2R through angiotensin
  1–9 binding has also been found to confer cardioprotection. Angiotensin 1–7 might
  induce the NO–soluble guanylyl cyclase pathway, thereby triggering vasodilatation
  via proto-oncogene Mas receptor (MasR) activation. Activation of this receptor can
  also reduce cardiac fibrosis by stimulating SHP1 and dual-specificity phosphatase
  (DUSP), consequently inhibiting p38 mitogen-activated protein kinase (MAPK) and
  ERK1 and ERK2. The KCa3.1 channel and mothers against decantaplegic homologue 2
  (SMAD2) and SMAD3 are downstream targets of ERK1 and ERK2, and are downregulated
  upon MasR activation. Additionally, angiotensin 1–7 exerts an anti-hypertrophic
  effect by inhibiting nuclear factor of activated T cells (NFAT) through a MasR–PI3K–AKT–NO–cGMP-dependent
  pathway. This anti-hypertrophic effect also depends on atrial natriuretic peptide
  (ANP) secretion during atrial pacing and is associated with activation of the Na+/H+
  exchanger (NHE1) and calcium/calmodulin-dependent protein kinase II (CaMKII) via
  the PI3K–AKT pathway. Cardiac hypertrophy can also be reduced by activation of the
  Mas-related G protein-coupled receptor member D (MRGD) by alamandine via adenylate
  cyclase (AC)–cAMP–protein kinase A (PKA) signalling.
pmcid: PMC7097090
papertitle: Counter-regulatory renin–angiotensin system in cardiovascular disease.
reftext: Maria Paz Ocaranza, et al. Nat Rev Cardiol. 2020;17(2):116-129.
pmc_ranked_result_index: '88865'
pathway_score: 0.941918
filename: 41569_2019_244_Fig3_HTML.jpg
figtitle: Counter-regulatory renin–angiotensin system in cardiovascular disease
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7097090__41569_2019_244_Fig3_HTML.html
  '@type': Dataset
  description: Signalling through the type 2 angiotensin II receptor (AT2R) can directly
    inhibit AT1R activation and thus antagonize the effects of angiotensin II. Stimulation
    of AT2R can also inhibit extracellular signal-regulated kinase 1 (ERK1) and ERK2
    by activating Src homology region 2 domain-containing phosphatase 1 (SHP1) and
    mitogen-activated protein kinase-phosphatase 1 (MKP1), which can result in attenuation
    of cardiac hypertrophy. AT2R can also activate the transcription factor promyelocytic
    zinc finger protein (PLZF), thereby inducing the expression of ribosomal protein
    S6 kinase β1 (p70S6K) and p85α expression and, in turn, eliciting protein synthesis.
    In addition, AT2R might trigger vasodilatation by activating the phosphatidylinositol-3-kinase
    (PI3K)–AKT–endothelial nitric oxide synthase (eNOS)–nitric oxide (NO)–cGMP pathway
    either via angiotensin 1–9-mediated activation– or by heterodimerization with
    bradykinin B2 receptor (B2R). Phosphorylation of AKT by activation of AT2R through
    angiotensin 1–9 binding has also been found to confer cardioprotection. Angiotensin
    1–7 might induce the NO–soluble guanylyl cyclase pathway, thereby triggering vasodilatation
    via proto-oncogene Mas receptor (MasR) activation. Activation of this receptor
    can also reduce cardiac fibrosis by stimulating SHP1 and dual-specificity phosphatase
    (DUSP), consequently inhibiting p38 mitogen-activated protein kinase (MAPK) and
    ERK1 and ERK2. The KCa3.1 channel and mothers against decantaplegic homologue
    2 (SMAD2) and SMAD3 are downstream targets of ERK1 and ERK2, and are downregulated
    upon MasR activation. Additionally, angiotensin 1–7 exerts an anti-hypertrophic
    effect by inhibiting nuclear factor of activated T cells (NFAT) through a MasR–PI3K–AKT–NO–cGMP-dependent
    pathway. This anti-hypertrophic effect also depends on atrial natriuretic peptide
    (ANP) secretion during atrial pacing and is associated with activation of the
    Na+/H+ exchanger (NHE1) and calcium/calmodulin-dependent protein kinase II (CaMKII)
    via the PI3K–AKT pathway. Cardiac hypertrophy can also be reduced by activation
    of the Mas-related G protein-coupled receptor member D (MRGD) by alamandine via
    adenylate cyclase (AC)–cAMP–protein kinase A (PKA) signalling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AR
  - ADCY2
  - ADCY3
  - ADCY5
  - ADCY6
  - ADCY8
  - ADCY9
  - ADCY10
  - ADCY4
  - ADCY1
  - ADCY7
  - PTPN6
  - ZBTB16
  - AKT2
  - AKT3
  - AKT1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - SLC9A1
  - DUSP4
  - DUSP5
  - DUSP1
  - DUSP2
  - DUSP3
  - DUSP6
  - MAPK3
  - MAPK1
  - MAPK14
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK9
  - MAPK10
  - MAK
  - CAMK2B
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - PPP3R2
  - PPP3CA
  - PPP3CB
  - PPP3CC
  - PPP3R1
  - SMAD3
  - SMAD2
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - NPPA
  - RPS6KB1
  - RPS6KB2
  - Alamandine
  - AT
  - Fibrosis Cardiac hypertrophy
genes:
- word: AT,R
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: AT,R
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: AT,R
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: SHP1
  symbol: SHP1
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN6
  entrez: '5777'
- word: PLZF
  symbol: PLZF
  source: hgnc_alias_symbol
  hgnc_symbol: ZBTB16
  entrez: '7704'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: NHE1
  symbol: NHE1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC9A1
  entrez: '6548'
- word: SHP1
  symbol: SHP1
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN6
  entrez: '5777'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP4
  entrez: '1846'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP5
  entrez: '1847'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP2
  entrez: '1844'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP3
  entrez: '1845'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: CaMKII
  symbol: CAMK2
  source: hgnc_alias_symbol
  hgnc_symbol: CAMK2B
  entrez: '816'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: NFAT+
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: NFAT+
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: NFAT+
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: NFAT+
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: NFAT+
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R2
  entrez: '5535'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CA
  entrez: '5530'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CB
  entrez: '5532'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CC
  entrez: '5533'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R1
  entrez: '5534'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: SMAD2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: ANP
  symbol: ANP
  source: hgnc_prev_symbol
  hgnc_symbol: NPPA
  entrez: '4878'
- word: PLZF
  symbol: PLZF
  source: hgnc_alias_symbol
  hgnc_symbol: ZBTB16
  entrez: '7704'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
chemicals:
- word: Alamandine
  source: MESH
  identifier: C581752
diseases:
- word: AT
  source: ''
  identifier: ''
- word: Fibrosis Cardiac hypertrophy
  source: MESH
  identifier: D006332
---
